Upregulation of FasL by LPA on ovarian cancer cell surface leads to apoptosis of activated lymphocytes
- 31 December 2004
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 95 (3) , 488-495
- https://doi.org/10.1016/j.ygyno.2004.07.052
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Cross-talk between Cytosolic Phospholipase A2α (cPLA2α) and Secretory Phospholipase A2 (sPLA2) in Hydrogen Peroxide-induced Arachidonic Acid Release in Murine Mesangial CellsJournal of Biological Chemistry, 2003
- MAPKs: new JNK expands the groupPublished by Elsevier ,2002
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Fas ligand and the fate of antitumour cytotoxic T lymphocytesImmunology, 2002
- Retinoic Acid and Vitamin E Modulate Expression and Release of CD178 in Carcinoma Cells: Consequences for Induction of Apoptosis in CD95-Sensitive CellsExperimental Cell Research, 2001
- Fas Ligand-Induced ApoptosisAnnual Review of Genetics, 1999
- Primary Ovarian Cancer Cultures are Resistant to Fas-Mediated ApoptosisGynecologic Oncology, 1999
- Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes.Journal of Clinical Investigation, 1998
- Mitogen-activated protein kinase cascades and regulation of gene expressionCurrent Opinion in Immunology, 1996
- Parallel signal processing among mammalian MAPKsTrends in Biochemical Sciences, 1995